ESR1 and breast carcinoma: Towards a better molecular understanding of endocrine resistance, we used clonally derived ERα-positive, antiestrogen-resistant breast cancer MCF7-cell models and demonstrated differential ERα PARylation in tamoxifen-resistant vs. –sensitive cells.